AbCellera Biologics (ABCL) Q4 2022 Earnings

21FebConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.1
0.11
0.33
0.54

Details

Expected EPS
0
Actual EPS
-0.1
Surprise EPS
-0.1
Surprise Percent
+∞%

Description

AbCellera Biologics (ABCL) has reported earnings of -0.1 per share for Q4 2022.

0 Comments

Share your thoughts